The cerebellum in Alzheimer's disease: Evaluating its role in cognitive decline

Brain

Volumn 141, Issue 1, 2018, Pages 37-47

  Jacobs, Heidi I L ^a,b,c   Hopkins, David A ^b,d   Mayrhofer, Helen C ^b   Bruner, Emiliano ^e   Van Leeuwen, Fred W ^b   Raaijmakers, Wijnand ^b   Schmahmann, Jeremy D ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DALHOUSIE UNIVERSITY   (Canada)

^e CENTRO NACIONAL DE INVESTIGACIÓN SOBRE LA EVOLUCIÓN HUMANA CENIEH   (Spain)

Author keywords

Alzheimer's disease; Cerebellum; Cognition; Modulation; Networks

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBELLUM; CEREBELLUM ATROPHY; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE EXACERBATION; DYSMETRIA; FUNCTIONAL NEUROIMAGING; HUMAN; NEUROIMAGING; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOMATOLOGY; COMPLICATION; DIAGNOSTIC IMAGING; PATHOLOGY;

ALZHEIMER DISEASE; CEREBELLUM; COGNITION DISORDERS; HUMANS; NEUROIMAGING;

EID: 85045901109     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awx194     Document Type: Article

References (146)

1. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol 2006; 63: 1763-9.
2. Ahmed Z, Cooper J, Murray TK, Garn K, McNaughton E, Clarke H, et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 2014; 127: 667-83.
3. Andel R, Gatz M, Pedersen NL, Reynolds CA, Johansson B, Berg S. Deficits in controlled processing may predict dementia: a twin study. J Gerontol B Psychol Sci Soc Sci 2001; 56: P347-55.
4. Andersen K, Andersen BB, Pakkenberg B. Stereological quantification of the cerebellum in patients with Alzheimer's disease. Neurobiol Aging 2012; 33: 197 e11-20.
5. Aso E, Lomoio S, Lopez-Gonzalez I, Joda L, Carmona M, Fernandez-Yague N, et al. Amyloid generation and dysfunctional immunopro-teasome activation with disease progression in animal model of familial Alzheimer's disease. Brain Pathol 2012; 22: 636-53.
6. Azzarelli B, Muller J, Ghetti B, Dyken M, Conneally PM. Cerebellar plaques in familial Alzheimer's disease (Gerstmann-Straussler-Scheinker variant?). Acta Neuropathol 1985; 65: 235-46.
7. Baldacara L, Borgio JG, Moraes WA, Lacerda AL, Montano MB, Tufik S, et al. Cerebellar volume in patients with dementia. Rev Bras Psiquitr 2011; 33: 122-9.
8. Balsters JH, Laird AR, Fox PT, Eickhoff SB. Bridging the gap between functional and anatomical features of cortico-cerebellar circuits using meta-analytic connectivity modeling. Hum Brain Mapp 2014; 35: 3152-69.
9. Barton RA, Harvey PH. Mosaic evolution of brain structure in mammals. Nature 2000; 405: 1055-8.
10. Barton RA, Venditti C. Rapid evolution of the cerebellum in humans and other great apes. Curr Biol 2014; 24: 2440-4.
11. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004; 25: 5-18; author reply 49-62.
12. Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, et al. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther 2011; 3: 1.
13. Baumann O, Borra RJ, Bower JM, Cullen KE, Habas C, Ivry RB, et al. Consensus paper: the role of the cerebellum in perceptual processes. Cerebellum 2015; 14: 197-220.
14. Bellebaum C, Daum I. Cerebellar involvement in executive control. Cerebellum 2007; 6: 184-92.
15. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 2003; 42: 33-84.
16. Bird TD, Sumi SM, Nemens EJ, Nochlin D, Schellenberg G, Lampe TH, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989; 25: 12-25.
17. Bosch B, Bartres-Faz D, Rami L, Arenaza-Urquijo EM, Fernandez-Espejo D, Junque C, et al. Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease. Cortex 2010; 46: 451-61.
18. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59.
19. Braak H, Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 1996; 92: 197-201.
20. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997a; 18: S85-8.
21. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997b; 18: 351-7.
22. Braak H, Braak E, Bohl J, Lang W. Alzheimer's disease: amyloid plaques in the cerebellum. J Neurol Sci 1989; 93: 277-87.
23. Braak H, Del Tredici K. Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 2004; 25: 19-23.
24. Braak H, Del Tredici K. Alzheimer's pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol 2011; 121: 589-95.
25. Braak H, Del Tredici K. Alzheimer's disease: pathogenesis and prevention. Alzheimers Dement 2012; 8: 227-33.
26. Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011; 70: 960-9.
27. Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, et al. Increased fMRI signal with age in familial Alzheimer's disease mutation carriers. Neurobiol Aging 2012; 33: 424 e11-21.
28. Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Thompson PM, et al. Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease. Hum Brain Mapp 2013; 34: 3308-19.
29. Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ. Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 2015; 16: 109-20.
30. Brock B, Basha R, DiPalma K, Anderson A, Harry GJ, Rice DC, et al. Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis. J Alzheimers Dis 2008; 13: 71-80.
31. Bruner E, Iriki A. Extending mind, visuospatial integration and the evolution of the parietal lobe in the human genus. Quat Int 2015; 405: 98-110.
32. Buckner RL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron 2013; 80: 807-15.
33. Buckner RL, Krienen FM. The evolution of distributed association networks in the human brain. Trends Cogn Sci 2013; 17: 648-65.
34. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 2009; 29: 1860-73.
35. Buckner RL, Wheeler ME. The cognitive neuroscience of remembering. Nat Rev Neurosci 2001; 2: 624-34.
36. Canu E, Frisoni GB, Agosta F, Pievani M, Bonetti M, Filippi M. Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage. Neurobiol Aging 2012; 33: 1023-33.
37. Carrasco MC, Guillem MJ, Redolat R. Estimation of short temporal intervals in Alzheimer's disease. Exp Aging Res 2000; 26: 139-51.
38. Cartford MC, Gould T, Bickford PC. A central role for norepinephrine in the modulation of cerebellar learning tasks. Behav Cogn Neurosci Rev 2004; 3: 131-8.
39. Castellazzi G, Palesi F, Casali S, Vitali P, Sinforiani E, Wheeler-Kingshott CA, et al. A comprehensive assessment of resting state networks: bidirectional modification of functional integrity in cere-bro-cerebellar networks in dementia. Front Neurosci 2014; 8: 223.
40. Cole G, Neal JW, Singhrao SK, Jasani B, Newman GR. The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis. Acta Neuropathol 1993; 85: 542-52.
41. Cole G, Williams P, Alldryck D, Singharo S. Amyloid plaques in the cerebellum in Alzheimer's disease. Clin Neuropathol 1989; 8: 188-91.
42. Costa AS, Rocha S, Machado A. Association of retrospective time estimation and severity of cognitive impairment. J Clin Exp Neuropsychol 2016; 38: 853-60.
43. D'Aes T, Marien P. Cognitive and affective disturbances following focal brainstem lesions: a review and report of three cases. Cerebellum 2015; 14: 317-40.
44. Demirtas-Tatlidede A, Freitas C, Cromer JR, Safar L, Ongur D, Stone WS, et al. Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia. Schizophr Res 2010; 124: 91-100.
45. Dickson DW, Wertkin A, Mattiace LA, Fier E, Kress Y, Davies P, et al. Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease. Acta Neuropathol 1990; 79: 486-93.
46. Dos Santos V, Thomann PA, Wustenberg T, Seidl U, Essig M, Schroder J. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011; 23: 411-20.
47. Du J, Sun B, Chen K, Zhang L, Liu S, Gu Q, et al. Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease. PLoS One 2009; 4: e5530.
48. Ehrenberg AJ, Nguy AK, Theofilas P, Dunlop S, Suemoto CK, Di Lorenzo Alho AT, et al. Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease. Neuropathol Appl Neurobiol 2017; 43: 393-408.
49. Flechsig P. Anatomie des menschlichen Gehirns und Ruckenmarks. Leipzig: George Thieme; 1920.
50. Fortea J, Sala-Llonch R, Bartres-Faz D, Bosch B, Llado A, Bargallo N, et al. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis 2010; 22: 909-22.
51. Fukutani Y, Cairns NJ, Rossor MN, Lantos PL. Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val->Ile) mutation cases: a morphometric investigation. J Neurol Sci 1997; 149: 177-84.
52. Gentier RJ, Verheijen BM, Zamboni M, Stroeken MM, Hermes DJ, Kusters B, et al. Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's disease. Front Neuroanat 2015; 9: 26.
53. Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003; 60: 1495-500.
54. Güell X, Hoche F, Schmahmann JD. Metalinguistic deficits in patients with cerebellar dysfunction: empirical support for the dysmetria of thought theory. Cerebellum 2015; 14: 50-8.
55. Guo CC, Tan R, Hodges JR, Hu X, Sami S, Hornberger M. Network-selective vulnerability of the human cerebellum to Alzheimer's disease and frontotemporal dementia. Brain 2016; 139: 1527-38.
56. Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, et al. Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biol Psychiatry 2013; 73: 454-63.
57. Haworth J, Phillips M, Newson M, Rogers PJ, Torrens-Burton A, Tales A. Measuring information processing speed in mild cognitive impairment: clinical versus research dichotomy. J Alzheimers Dis 2016; 51: 263-75.
58. He Y, Chen Z, Gong G, Evans A. Neuronal networks in Alzheimer's disease. Neuroscientist 2009; 15: 333-50.
59. He Y, Wang L, Zang Y, Tian L, Zhang X, Li K, et al. Regional coherence changes in the early stages of Alzheimer's disease: a combined structural and resting-state functional MRI study. Neuroimage 2007; 35: 488-500.
60. Heckmann JM, Low WC, de Villiers C, Rutherfoord S, Vorster A, Rao H, et al. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease. Brain 2004; 127: 133-42.
61. Herculano-Houzel S. Coordinated scaling of cortical and cerebellar numbers of neurons. Front Neuroanat 2010; 4: 12.
62. Herculano-Houzel S. The remarkable, yet not extraordinary, human brain as a scaled-up primate brain and its associated cost. Proc Natl Acad Sci USA 2012; 109 (SUPPL. 1): 10661-8.
63. Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, et al. Amyloid-beta deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain 2015; 138: 1023-35.
64. Iriki A, Taoka M. Triadic (ecological, neural, cognitive) niche construction: a scenario of human brain evolution extrapolating tool use and language from the control of reaching actions. Philos Trans R Soc Lond B Biol Sci 2012; 367: 10-23.
65. Irmler M, Gentier RJ, Dennissen FJ, Schulz H, Bolle I, Holter SM, et al. Long-term proteasomal inhibition in transgenic mice by UBB(+ 1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients. Acta Neuropathol 2012; 124: 187-97.
66. Jacobs HI, Radua J, Luckmann HC, Sack AT. Meta-analysis of functional network alterations in Alzheimer's disease: toward a network biomarker. Neurosci Biobehav Rev 2013; 37: 753-65.
67. Jacobs HI, Van Boxtel MP, Heinecke A, Gronenschild EH, Backes WH, Ramakers IH, et al. Functional integration of parietal lobe activity in early Alzheimer disease. Neurology 2012a; 78: 352-60.
68. Jacobs HIL, Van Boxtel MPJ, Jolles J, Verhey FRJ, Uylings HBM. Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings. Neurosci Biobehav Rev 2012b; 36: 297-309.
69. Jacobs HIL, Wiese S, van de Ven V, Gronenschild EHBM, Verhey FRJ, Matthews PM. Relevance of parahippocampal-locus coeruleus connectivity to memory in early dementia Neurobiol Aging 2014; 36: 618-26.
70. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004; 13: 159-70.
71. Jernigan TL, Archibald SL, Fennema-Notestine C, Gamst AC, Stout JC, Bonner J, et al. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging 2001; 22: 581-94.
72. Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement 2014a; 10: 844-52.
73. Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mosch E, Kaduszkiewicz H, et al. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement 2014b; 10: 76-83.
74. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 1989; 135: 309-19.
75. Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011; 70: 532-40.
76. Kelly RM, Strick PL. Cerebellar loops with motor cortex and pre-frontal cortex of a nonhuman primate. J Neurosci 2003; 23: 8432-44.
77. Kong Y, Ruan L, Qian L, Liu X, Le Y. Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upre-gulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. J Neurosci 2010; 30: 11848-57.
78. Lalli MA, Cox HC, Arcila ML, Cadavid L, Moreno S, Garcia G, et al. Origin of the PSEN1 E280A mutation causing early-onset Alzheimer's disease. Alzheimers Dement 2014; 10: S277-S283.e10.
79. Larner AJ. The cerebellum in Alzheimer's disease. Dement Geriatr Cogn Disord 1997; 8: 203-9.
80. Leggio M, Molinari M. Cerebellar sequencing: a trick for predicting the future. Cerebellum 2015; 14: 35-8.
81. Leiner HC. Solving the mystery of the human cerebellum. Neuropsychol Rev 2010; 20: 229-35.
82. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med 1996; 2: 1146-50.
83. Lezak MD. The behavioural geography of the brain: functional organization of the posterior cortex. In: Lezak MD, editor. Neuropsychological assessment. Oxford: Oxford University Press; 1995. p. 71-86.
84. Li H, Liang Y, Chen K, Li X, Shu N, Zhang Z, et al. Different patterns of white matter disruption among amnestic mild cognitive impairment subtypes: relationship with neuropsychological performance. J Alzheimers Dis 2013; 36: 365-76.
85. Li YT, Woodruff-Pak DS, Trojanowski JQ. Amyloid plaques in cere-bellar cortex and the integrity of Purkinje cell dendrites. Neurobiol Aging 1994; 15: 1-9.
86. Lomoio S, Lopez-Gonzalez I, Aso E, Carmona M, Torrejon-Escribano B, Scherini E, et al. Cerebellar amyloid-beta plaques: disturbed cortical circuitry in AbetaPP/PS1 transgenic mice as a model of familial Alzheimer's disease. J Alzheimers Dis 2012; 31: 285-300.
87. Luck T, Luppa M, Matschinger H, Jessen F, Angermeyer MC, RiedelHeller SG. Incident subjective memory complaints and the risk of subsequent dementia. Acta Psychiatr Scand 2015; 131: 290-6.
88. Mackenzie IR, Frick P, Neumann M. The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 2014; 127: 347-57
89. Mann DM, Jones D, Prinja D, Purkiss MS. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol 1990; 80: 318-27.
90. Manto M, Mariën P. Schmahmann's syndrome - identification of the third cornerstone of clinical ataxiology. Cerebellum Ataxias 2015; 2: 2.
91. Marcyniuk B, Mann DM, Yates PO. The topography of cell loss from locus caeruleus in Alzheimer's disease. J Neurol Sci 1986; 76: 335-45.
92. Mariën P, D'Aes T. "Brainstem cognitive affective syndrome" following disruption of the cerebrocerebellar network. Cerebellum 2015; 14: 221-5.
93. Mascalchi M, Ginestroni A, Toschi N, Poggesi A, Cecchi P, Salvadori E, et al. The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study. Hum Brain Mapp 2014; 35: 819-30.
94. Mavroudis IA, Fotiou DF, Adipepe LF, Manani MG, Njau SD, Psaroulis D, et al. Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer's disease. Am J Alzheimers Dis Other Demen 2010; 25: 585-91.
95. Mavroudis IA, Manani MG, Petrides F, Petsoglou K, Njau SD, Costa VG, et al. Dendritic and spinal pathology of the Purkinje cells from the human cerebellar vermis in Alzheimer's disease. Psychiatria Danubina 2013; 25: 221-6.
96. McLaren DG, Sreenivasan A, Diamond EL, Mitchell MB, Van Dijk KR, Deluca AN, et al. Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease. Neurodegener Dis 2012; 9: 176-86.
97. Molinari M, Leggio MG. Cerebellar information processing and visuospatial functions. Cerebellum 2007; 6: 214-20.
98. Moller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, et al. Different patterns of gray matter atrophy in early-and late-onset Alzheimer's disease. Neurobiol Aging 2013; 34: 2014-22.
99. Ogomori K, Kitamoto T, Tateishi J, Sato Y, Suetsugu M, Abe M. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 1989; 134: 243-51.
100. Olazaran J, Hernandez-Tamames JA, Molina E, Garcia-Polo P, Dobato JL, Alvarez-Linera J, et al. Clinical and anatomical correlates of gait dysfunction in Alzheimer's disease. J Alzheimers Dis 2013; 33: 495-505.
101. Pro JD, Smith CH, Sumi SM. Presenile Alzheimer disease: amyloid plaques in the cerebellum. Neurology 1980; 30: 820-5.
102. Purushothuman S, Johnstone DM, Nandasena C, Eersel J, Ittner LM, Mitrofanis J, et al. Near infrared light mitigates cerebellar pathology in transgenic mouse models of dementia. Neurosci Lett 2015; 591: 155-9.
103. Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol 2012; 11: 1048-56.
104. Rilling JK. Human and non-human primate brains: are they allometrically scaled versions of the same design? Evol Anthropol 2006; 15: 65-67.
105. Roberts JL, Anderson ND, Guild E, Cyr AA, Jones RS, Clare L. The benefits of errorless learning for people with amnestic mild cognitive impairment. Neuropsychol Rehabil 2016: 1-13.
106. Rub U, Del Tredici K, Schultz C, Thal DR, Braak E, Braak H. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol 2001; 101: 555-64.
107. Rub U, Stratmann K, Heinsen H, Turco DD, Seidel K, Dunnen W, et al. The Brainstem Tau cytoskeletal pathology of Alzheimer's disease: a brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance. Curr Alzheimer Res 2016; 13: 1178-97.
108. Rudzinski LA, Fletcher RM, Dickson DW, Crook R, Hutton ML, Adamson J, et al. Early onset familial Alzheimer disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1. Alzheimer Dis Assoc Disord 2008; 22: 299-307.
109. Salmon DP. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Curr Top Behav Neurosci 2012; 10: 187-212.
110. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 2009; 10: 211-23.
111. Saunders NL, Summers MJ. Attention and working memory deficits in mild cognitive impairment. J Clin Exp Neuropsychol 2010; 32: 350-7.
112. Schmahmann JD. An emerging concept. The cerebellar contribution to higher function. Arch Neurol 1991; 48: 1178-87.
113. Schmahmann JD. From movement to thought: anatomic substrates of the cerebellar contribution to cognitive processing. Hum Brain Mapp 1996; 4: 174-98.
114. Schmahmann JD. The cerebellum and cognition. San Diego: Academic; 1997.
115. Schmahmann JD. Dysmetria of thought: clinical consequences of cere-bellar dysfunction on cognition and affect. Trends Cogn Sci 1998; 2: 362-71.
116. Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16: 367-78.
117. Schmahmann JD. Cerebellum in Alzheimer's disease and frontotemporal dementia: not a silent bystander. Brain 2016; 139: 1314-8.
118. Schmahmann JD, Anderson CM, Newton N, Ellis R. The function of the cerebellum in cognition, affect and consciousness. Empirical support for the embodied mind. Conscious Emot 2001; 2: 273-309.
119. Schmahmann JD, Pandya DN. The cerebrocerebellar system. In: Schmahmann JD, editor. The cerebellum and cognition, Vol. 41. San Diego: Academic Press; 1997. p. 31-60.
120. Schmahmann JD, Sherman JC. Cerebellar cognitive affective syndrome. Int Rev Neurobiol 1997; 41: 433-40.
121. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998; 121 (Pt 4): 561-79.
122. Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum-insights from the clinic. Cerebellum 2007; 6: 254-67.
123. Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009; 62: 42-52.
124. Sepulveda-Falla D, Barrera-Ocampo A, Hagel C, Korwitz A, Vinueza-Veloz MF, Zhou K, et al. Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis. J Clin Invest 2014; 124: 1552-67.
125. Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, et al. Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease. Brain Pathol 2011; 21: 452-63.
126. Sjobeck M, Englund E. Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes. Dement Geriatr Cogn Disord 2001; 12: 211-8.
127. Smaers JB. Modeling the evolution of the cerebellum: from macroevolution to function. Prog Brain Res 2014; 210: 193-216.
128. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, et al. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 2010; 12: 27-43.
129. Stoodley CJ. The cerebellum and cognition: evidence from functional imaging studies. Cerebellum 2012; 11: 352-65.
130. Stoodley CJ, Schmahmann JD. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage 2009; 44: 489-501.
131. Stoodley CJ, Valera EM, Schmahmann JD. Functional topography of the cerebellum for motor and cognitive tasks: an fMRI study. Neuroimage 2012; 59: 1560-70.
132. Suenaga T, Hirano A, Llena JF, Ksiezak-Reding H, Yen SH, Dickson DW. Modified Bielschowsky and immunocytochemical studies on cerebellar plaques in Alzheimer's disease. J Neuropathol Exp Neurol 1990; 49: 31-40.
133. Tan RH, Devenney E, Dobson-Stone C, Kwok JB, Hodges JR, Kiernan MC, et al. Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 2014; 9: e105632.
134. Teipel SJ, Meindl T, Wagner M, Stieltjes B, Reuter S, Hauenstein KH, et al. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 2010; 22: 507-22.
135. Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58: 1791-800.
136. Theofilas P, Ehrenberg AJ, Dunlop S, Di Lorenzo Alho AT, Nguy A, Leite RE, et al. Locus coeruleus volume and cell population changes during Alzheimer's disease progression: a stereological study in human postmortem brains with potential implication for early-stage biomarker discovery. Alzheimers Dement 2017; 13: 236-246.
137. Thomann PA, Schlafer C, Seidl U, Santos VD, Essig M, Schroder J. The cerebellum in mild cognitive impairment and Alzheimer's disease-a structural MRI study. J Psychiatr Res 2008; 42: 1198-202.
138. Tomic JL, Pensalfini A, Head E, Glabe CG. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction. Neurobiol Dis 2009; 35: 352-8.
139. Venneri A, Gorgoglione G, Toraci C, Nocetti L, Panzetti P, Nichelli P. Combining neuropsychological and structural neuroimaging indicators of conversion to Alzheimer's disease in amnestic mild cognitive impairment. Curr Alzheimer Res 2011; 8: 789-97.
140. Wang HY, D'Andrea MR, Nagele RG. Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells. Neurobiol Aging 2002; 23: 213-23.
141. Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, et al. Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations. Brain Res 1999; 818: 41-50.
142. Whiting BA, Barton RA. The evolution of the cortico-cerebellar complex in primates: anatomical connections predict patterns of correlated evolution. J Hum Evol 2003; 44: 3-10.
143. Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 2012; 135: 794-806.
144. Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord 1999; 13: 226-31.
145. Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, Liu QY, et al. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neurosci Bull 2011; 27: 221-32.
146. Zhang H, Sachdev PS, Wen W, Kochan NA, Crawford JD, Brodaty H, et al. Gray matter atrophy patterns of mild cognitive impairment subtypes. J Neurol Sci 2012; 315: 26-32.